Acadia Pharmaceuticals sell nvestor
Start price
30.09.23
/
50%
€19.60
Target price
30.09.24
€9.00
Performance (%)
11.22%
End price
14.10.23
€21.80
Summary
This prediction ended on 14.10.23 with a price of €21.80. The prediction closed with a disappointing performance of 11.22%. nvestor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 1.153% | 1.153% |
| iShares Core DAX® | 3.178% | 0.980% |
| iShares Nasdaq 100 | 2.972% | 0.925% |
| iShares Nikkei 225® | 0.545% | -4.556% |
| iShares S&P 500 | 2.367% | 0.833% |
According to nvestor what are the pros and cons of Acadia Pharmaceuticals for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Little innovation
Few uniques
Dependend from some customers or products
Growths slower than the competition
high free float
Significant cyclical dependencies
Little known brand
Business model of the past or high risk
Bad rating
Bad culture
Sustainability is little important
Higher risks for its business
Below average Marketposition
Comments by nvestor for this prediction
In the thread Acadia Pharmaceuticals diskutieren
In the thread Trading Acadia Pharmaceuticals
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.